Axogen, Inc. Common Stock
Symbol: AXGN (NASDAQ)
17.21
▼ (-1.06%) -0.185
Company Description:
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Key Stats
- Today's Open: $17.2
- Today's High: $17.588
- Today's Low: $16.79
- Today's Volume: 963.75K
- Yesterday Close: $17.39
- Yesterday High: $17.5832
- Yesterday Low: $17.02
- Yesterday Volume: 784.99K
- Last Min Volume: 3
- Last Min High: $17.205
- Last Min Low: $17.205
- Last Min VWAP: $17.205
Company Profile
- Name: Axogen, Inc. Common Stock
- Website: https://www.axogeninc.com
- Listed Date: 1986-12-17
- Location: ALACHUA, FL
- Market Status: Active
- CIK Number: 0000805928
- SIC Code: 3845
- SIC description: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
- Market Cap: $800.16M
- Round Lot: 100
- Outstanding Shares: 46.01M
- Asset Type: CS
RECENT FILINGS FOR AXGN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-16 | 4 | View |
| 2025-08-25 | 8-K | View |
| 2025-08-05 | S-8 | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 8-K | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
| 2025-06-11 | 4 | View |
Latest News on AXGN